Key result
ICDs markedly reduce arrhythmic and sudden death rates in patients with malignant ventricular tachyarrhythmias.
Why the study?
Do implantable cardioverter-defibrillators reduce arrhythmic/sudden death rates in patients with malignant ventricular tachyarrhythmias?
Population
Patients with either drug-refractory sustained ventricular tachycardia, ventricular fibrillation or…
Design
Review
Authors
Loading...
Supports ICD consideration in malignant ventricular tachyarrhythmias; leaves open optimal selection and net benefit versus modern therapies.
Do implantable cardioverter-defibrillators reduce arrhythmic/sudden death rates in patients with malignant ventricular tachyarrhythmias?
ICD therapy provides a marked reduction in arrhythmic and sudden death rates in patients with malignant ventricular tachyarrhythmias, supported by significant technological advancements.
Sanjeev Saksena (2008) conducted a review in Malignant Ventricular Tachyarrhythmias. Implantable Cardioverter-Defibrillators (ICD) was evaluated on Arrhythmic/sudden death rates. Implantable cardioverter-defibrillators markedly reduce expected arrhythmic and sudden death rates in patients with malignant ventricular tachyarrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: